Merck & Co

Merck & Co

Pharmaceuticals
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

$353.4B

Market Cap • 11/17/2026

1970

(56 years)

Founded

1949

(77 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

S&P500 Participant

Index Composite • 2026

Valuation

P/B

7,9

P/S

5,2

P/EBITDA

27,6

P/OCF

18,9

P/FCF

24

P/E

147,8

BVPS

18,2

EPS

1

Market Cap

Market Cap

353,4B

EV

397,6B

EV/Revenue

5,9

EV/EBITDA

31,1

EV/EBIT

72,9

Payout

Dividend Per Share

3,4

Dividend Yield

2,4%

Buyback Yield

0,9%

Total Yield

3,2%

Dividend Yield 5Y

2,8%

Payout

341,1%

Retained Earnings

66,2B

Profitability

Gross Margin

71,8%

EBITDA Margin

19%

EBIT Margin

8,1%

Net Margin

3,6%

D&A/EBITDA

0%

R&D/Revenue

45,6%

Capex/Revenue

5,9%

Capex/D&A

53,9%

Capex/OCF

21,2%

SBC/OCF

5,7%

% PPE

19,5%

% Goodwill

16,5%

ROE

5,1%

ROIC

3,1%

Growth

CAGR Revenue 5Y

7,9%

CAGR Op. Income 5Y

-2,4%

CAGR Net Income 5Y

-16,2%

CAGR EPS 5Y

-18,1%

CAGR OCF 5Y

62,6%

Leverage

N.D./EBITDA

3,4

Debt/Equity

0%

Current Ratio

1,4

Quick Ratio

0,8

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium